According to the details, the authority has received over 227 applications relating to different verification concerns after the one-window cell resumed operations owing to the government-sanctioned ease in the country’s lockdown restrictions.

These applications include requests on property transfers, estate management, procurement of NOCs, approvals of building plans, and more. Out of these applications, 117 have been resolved already.

The information was revealed by the Director-General FDA Muhammad Suhail Khawaja in a review meeting held to analyze the performance of the one-window cell counter. During the meeting, the pace and quality of sectional performance and said that the FDA was committed to maintaining the highest standard of services.